Edition:
India

Altimmune Inc (ALT.OQ)

ALT.OQ on NASDAQ Stock Exchange Global Market

2.13USD
1:30am IST
Change (% chg)

$0.01 (+0.47%)
Prev Close
$2.12
Open
$2.11
Day's High
$2.14
Day's Low
$2.10
Volume
8,813
Avg. Vol
58,413
52-wk High
$36.25
52-wk Low
$1.70

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.23 December 23 Aug 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 -- -- --
(2) OUTPERFORM 1 -- -- --
(3) HOLD 0 -- -- --
(4) UNDERPERFORM 0 -- -- --
(5) SELL 0 -- -- --
No Opinion 0 -- -- --
Mean Rating 2.00 -- -- --

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1 2.63 2.63 2.63 --
Quarter Ending Dec-19 1 2.58 2.58 2.58 --
Year Ending Dec-19 1 10.58 10.58 10.58 --
Year Ending Dec-20 1 10.31 10.31 10.31 --
Earnings (per share)
Quarter Ending Sep-19 1 -0.23 -0.23 -0.23 --
Quarter Ending Dec-19 1 -0.24 -0.24 -0.24 --
Year Ending Dec-19 1 -0.98 -0.98 -0.98 --
Year Ending Dec-20 1 -1.00 -1.00 -1.00 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 3.52 2.59 0.93 26.48
Quarter Ending Sep-18 2.52 2.63 0.11 4.52
Quarter Ending Jun-18 3.01 2.42 0.59 19.57
Quarter Ending Mar-18 1.20 2.69 1.49 124.25
Quarter Ending Dec-17 1.20 2.81 1.61 134.08

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 2.63 2.63 -- -- --
Quarter Ending Dec-19 2.58 2.58 -- -- --
Year Ending Dec-19 10.58 10.58 -- -- --
Year Ending Dec-20 10.31 10.31 -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 -- --
Quarter Ending Dec-19 0 0 -- --
Year Ending Dec-19 0 0 -- --
Year Ending Dec-20 0 0 -- --
Earnings